Reactiv8

4 results

Shares in Mainstay Medical, the Irish medical device company targeting chronic back pain, crashed to record lows after a key clinical trial failed.

Shares in Mainstay Medical, the Irish medical device company targeting chronic back pain, crashed to record lows after a key clinical trial failed. M(...)

The ReActiv8 unit is designed to treat disabling pain in patients with chronic lower back pain through the use of an implant that stimulates nerves to strengthen muscles in the lower back

Back pain group Mainstay Medical has successfully implanted 204 patients with its Reactiv8 device as part of a clinical trial to access the key United(...)

Mainstay Medical chief executive Peter Crosby.

Irish medical device company Mainstay Medical plans to raise up to €26.4 million in a stock market flotation (...)

“The results are, for us at least, pretty exciting. They show that the therapy that’s delivered by our product appears to work and the results have certainly captured the attention of the clinical community with which we work,” said Mainstay chief executive Peter Crosby.

Mainstay Medical, an Irish medtech company targeting chronic lower back pain, is starting clinical trials on its Reactiv8 implantable device. (...)